Reirradiation of normal tissues: Preclinical radiobiological data;Réirradiation des tissus sains: Données radiobiologiques précliniques

Cancer/Radiotherapie

Volumn 14, Issue 6-7, 2010, Pages 412-415

  Bourgier, C ^a   Vozenin, M C ^a   Deutsch, E ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Normal tissues response; Reirradiation

Indexed keywords

ALPHA TOCOPHEROL; ANTIFIBROTIC AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PENTOXIFYLLINE; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE TOXICITY; CANCER RADIOTHERAPY; CELL DAMAGE; CHRONIC INFLAMMATION; CHRONIC TOXICITY; CYTOKINE RELEASE; DOSIMETRY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IRRADIATION; KIDNEY INJURY; LUNG DISEASE; LUNG FIBROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIOBIOLOGY; RETREATMENT; RISK BENEFIT ANALYSIS; SHORT SURVEY; SKIN TOXICITY; TREATMENT INDICATION; ANIMAL; ANTIBODY SPECIFICITY; BONE MARROW; FIBROSIS; HAPLORHINI; MOUSE; NERVOUS SYSTEM; PATHOLOGY; RADIATION DOSE; RADIATION INJURIES; RADIATION INJURIES, EXPERIMENTAL; RADIATION RESPONSE; RADIOTHERAPY; RAT; SKIN; VISCERA;

ANIMALS; BONE MARROW; DOSE-RESPONSE RELATIONSHIP, RADIATION; FIBROSIS; HAPLORHINI; HUMANS; MICE; NERVOUS SYSTEM; ORGAN SPECIFICITY; RADIATION INJURIES; RADIATION INJURIES, EXPERIMENTAL; RADIATION TOLERANCE; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RATS; SKIN; VISCERA;

EID: 77957265171     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2010.06.007     Document Type: Short Survey

References (30)

1. Ang K.K., Price R.E., Stephens L.C., Jiang G.L., Feng Y., Schultheiss T.E., et al. The tolerance of primate spinal cord to reirradiation. Int J Radiat Oncol Biol Phys 1993, 25:459-464.
2. Baumann M., Budach V., Appold S. Radiation tolerance of the human spinal cord. Strahlenther Onkol 1994, 170:131-139.
3. Bourgier C., Haydont V., Milliat F., Francois A., Holler V., Lasser P., et al. Inhibition of rhokinase modulates radiation-induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expression. Gut 2005, 54:336-343.
4. Brown J.M., Probert J.C. Early and late radiation changes following a second course of irradiation. Radiology 1975, 115:711-716.
5. Delanian S., Baillet F., Huart J., Lefaix J.L., Maulard C., Housset M. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: clinical trial. Radiother Oncol 1994, 32:12-20.
6. Delanian S., Lefaix J.L. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol 2004, 73:119-131.
7. Delanian S., Porcher R., Balla-Mekias S., Lefaix J.L. Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol 2003, 21:2545-2550.
8. Delanian S., Porcher R., Rudant J., Lefaix J.L. Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol 2005, 23:8570-8579.
9. Denham J.W., Hauer-Jensen M. The radiotherapeutic injury - a complex "wound" Radiother Oncol 2002, 63:129-145.
10. Haydont V., Bourgier C., Pocard M., Lusinchi A., Aigueperse J., Mathe D., et al. Pravastatin Inhibits the Rho/CCN2/extracellular matrix cascade in human fibrosis explants and improves radiation-induced intestinal fibrosis in rats. Clin Cancer Res 2007, 13:5331-5340.
11. Haydont V., Bourgier C., Vozenin-Brotons M.C. Rho/Rock pathway as a molecular target for modulation of intestinal radiation-induced toxicity. Br J Radiol 2007, 80(Spec no. 1):S32-S40.
12. Hornsey S., White A. Isoeffect curve for radiation myelopathy. Br J Radiol 1980, 53:168-169.
13. Lartigau E., Dubray B., Mornex F. Mécanismes biologiques des effets tardifs des radiations ionisantes. 1997, 1:669-676.
14. Maciejewski B., Zajusz A., Pilecki B., Swiatnicka J., Skladowski K., Dorr W., et al. Acute mucositis in the stimulated oral mucosa of patients during radiotherapy for head and neck cancer. Radiother Oncol 1991, 22:7-11.
15. Martin M., Delanian S., Sivan V., Vozenin-Brotons M.C., Reisdorf P., Lawrence D., et al. Fibrose superficielle radio-induite et TGF1. Cancer Radiother 2000, 4:369-384.
16. Molla M., Gironella M., Miquel R., Tovar V., Engel P., Biete A., et al. Relative roles of ICAM-1 and VCAM-1 in the pathogenesis of experimental radiation-induced intestinal inflammation. Int J Radiat Oncol Biol Phys 2003, 57:264-273.
17. Molla M., Panes J. Radiation-induced intestinal inflammation. World J Gastroenterol 2007, 13:3043-3046.
18. Molla M., Panes J., Casadevall M., Salas A., Conill C., Biete A., et al. Influence of dose-rate on inflammatory damage and adhesion molecule expression after abdominal radiation in the rat. Int J Radiat Oncol Biol Phys 1999, 45:1011-1018.
19. Nieder C., Grosu A.L., Andratschke N.H., Molls M. Update of human spinal cord reirradiation tolerance based on additional data from 38 patients. Int J Radiat Oncol Biol Phys 2006, 66:1446-1449.
20. Probert J.C., Brown J.M. A comparison of three and five times weekly fractionation on the response of normal and malignant tissues of the C3H mouse. Br J Radiol 1974, 47(563):775-780.
21. Simmonds R.H., Hopewell J.W., Robbins M.E. Residual radiation-induced injury in dermal tissue: implications for retreatment. Br J Radiol 1989, 62:915-920.
22. Stewart F.A., Luts A., Lebesque J.V. The lack of long-term recovery and reirradiation tolerance in the mouse kidney. Int J Radiat Biol 1989, 56:449-462.
23. Stewart F.A., Oussoren Y., Luts A. Long-term recovery and reirradiation tolerance of mouse bladder. Int J Radiat Oncol Biol Phys 1990, 18:1399-1406.
24. Stewart F.A., Oussoren Y., Van Tinteren H., Bentzen S.M. Loss of reirradiation tolerance in the kidney with increasing time after single or fractionated partial tolerance doses. Int J Radiat Biol 1994, 66:169-179.
25. Terry N.H., Tucker S.L., Travis E.L. Residual radiation damage in murine lung assessed by pneumonitis. Int J Radiat Oncol Biol Phys. 1988, 14:929-938.
26. Terry N.H., Tucker S.L., Travis E.L. Time course of loss of residual radiation damage in murine skin assessed by retreatment. Int J Radiat Biol 1989, 55:271-283.
27. van der Kogel A.J., Sissingh H.A., Zoetelief J. Effect of X-rays and neutrons on repair and regeneration in the rat spinal cord. Int J Radiat Oncol Biol Phys 1982, 8:2095-2097.
28. Van der Schueren E., Van den Bogaert W., Vanuytsel L., Van Limbergen E. Radiotherapy by multiple fractions per day (MFD) in head and neck cancer: acute reactions of skin and mucosa. Int J Radiat Oncol Biol Phys 1990, 19:301-311.
29. Wynn T.A. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004, 4:583-594.
30. Yang F.T., Lord B.I., Hendry J.H. Gamma irradiation of the fetus damages the developing hemopoietic microenvironment rather than the hemopoietic progenitor cells. Radiat Res 1995, 141:309-313.